Vegfr2-169 Peptide Vaccine
Vegfr2-169 Peptide Vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.
Vegfr2-169 Peptide Vaccine is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)).
| Trade Name | Vegfr2-169 Peptide Vaccine |
| Generic | VEGFR2-169 |
| VEGFR2-169 Other Names | Elpamotide, Vegfr2-169 peptide vaccine |
| Type | |
| Formula | C47H76N16O13 |
| Weight | Average: 1073.224 Monoisotopic: 1072.577776571 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Vegfr2-169 Peptide Vaccine
